MBX Biosciences

MBX

MBX MBX Biosciences NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    MBX Chart
    See on advanced chart >

    About

    MBX Biosciences, Inc. was founded in the Indiana in August 2018 and converted to a Delaware corporation in April 2019. They are a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the...
    Read More
    • Highlight
      A clinical-stage biopharmaceutical company focused on discovering and developing novel precision peptide therapeutics for the treatment of endocrine and metabolic diseases
      • Industry
      Pharmaceuticals
    • Exchange
      NASDAQ
    • Listing Date
      09/13/2024
    • Established Date
      Invalid Date
    • Full-time Employees
      36
    • Address
      11711 N. Meridian Street Suite 300 Carmel Indiana 46032
    • Tel
      1-317-6590200
    • Website
      www.mbxbio.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock